MayPall Inc
Natural mouthwash safe to swallow using maple, green tea, and xylitol to prevent cavities.
Website: https://www.maypall.com/
Cover Block
PUBLIC
| Attribute | Value |
|---|---|
| Company | MayPall Inc |
| Tagline | Natural mouthwash safe to swallow using maple, green tea, and xylitol to prevent cavities. |
| Headquarters | Laramie, Wyoming, United States |
| Stage | Pre-Seed |
| Business Model | Direct-to-Consumer (DTC) |
| Industry | Healthtech |
| Technology | Biotech / Life Sciences |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
| Accelerator | gBETA Wyoming Summer 2024 [wyomingnews.com, July 2024] |
Links
PUBLIC
- Website: https://www.maypall.com/
- LinkedIn: https://www.linkedin.com/company/maypall
Executive Summary
PUBLIC MayPall Inc is a pre-seed oral care startup commercializing a natural, swallow-safe mouthwash derived from University of Wyoming laboratory research. It presents a rare example of biotech innovation emerging from the state's academic ecosystem [Cowboy State Daily, Oct 2025].
The company's core proposition is a direct-to-consumer product. It uses compounds from maple, green tea, and birch xylitol to prevent cavity-causing bacteria from adhering to teeth. This positions it as a safer alternative for children and adults seeking alcohol-free and fluoride-free options [Maypall.com].
The venture originated from foundational research by University of Wyoming Professor Mark Gomelsky. His work on bacterial adhesion mechanisms inspired the formulation [Maypall.com]. This academic pedigree provides scientific credibility, though the commercial team behind the spinout is not publicly named.
The business model is straightforward DTC e-commerce. It features a subscription service delivering two bottles every two months at $9.50 per bottle [Maypall.com].
MayPall's public validation consists of selection for the gBETA Wyoming Summer 2024 accelerator program. This signals local institutional support [wyomingnews.com, July 2024]. No funding rounds, revenue metrics, or founding team details are publicly disclosed. This marks an exceptionally early-stage opportunity.
Data Accuracy: YELLOW -- Core product claims and accelerator participation are confirmed; founding story is attributed but lacks independent corroboration; financial and team data are absent.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Pre-Seed |
| Business Model | Direct-to-Consumer (DTC) |
| Industry / Vertical | Healthtech |
| Technology Type | Biotech / Life Sciences |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
Company Overview
PUBLIC
MayPall Inc is a pre-seed oral care startup that began as a scientific discovery in an academic laboratory.
The company's origins trace to research conducted by Professor Mark Gomelsky at the University of Wyoming. His team studied how harmful bacteria adhere to surfaces [Maypall.com, Unknown]. This foundational work on bacterial adhesion directly inspired MayPall's natural mouthwash formula. The company is an academic spinout [Cowboy State Daily, Oct 2025].
It is headquartered in Laramie, Wyoming. It operates a direct-to-consumer sales model.
A key early milestone was selection for the gBETA Wyoming Summer 2024 accelerator program. This is a statewide initiative run by venture capital firm gener8tor [wyomingnews.com, July 2024]. This participation represents primary public validation of commercial efforts beyond laboratory genesis.
The company maintains a UK-registered entity named MEYPAL LTD. Its listed Standard Industrial Classification code (46310 for wholesale of fruit and vegetables) does not align with oral care. This suggests a possible holding or administrative structure.
The founding team and external funding rounds have not been publicly disclosed. The public narrative anchors on research-backed formulation and accelerator participation. No subsequent news covers product launches, partnerships, or financial milestones.
Data Accuracy: YELLOW -- Company website and local news provide founding story and accelerator participation; key details like founding date and team are unconfirmed.
Product and Technology
MIXED
MayPall's commercial proposition is a direct-to-consumer oral rinse. It distinguishes itself on a single claim: safe to swallow.
This departs from conventional mouthwashes with alcohol, fluoride, or other non-ingestible ingredients, especially for children. The product line uses 16.9-ounce bottles. It positions for all ages with flavors: maple for adults, watermelon and bubble gum for kids [Maypall.com].
The technology applies academic research into bacterial adhesion. The formula originated from University of Wyoming lab work by Professor Mark Gomelsky. It explored how harmful bacteria like Listeria monocytogenes stick to surfaces [Maypall.com].
The commercial adaptation blends natural compounds. Extracts from maple and green tea combine with birch-derived xylitol. This prevents cavity-causing bacteria from adhering to tooth enamel [Maypall.com]. The mouthwash is alcohol-free, fluoride-free. It neutralizes harmful acids in the mouth.
Go-to-market is DTC via the website. The core offering is subscription: two bottles every two months, with one-time purchases. A free sample program for dental offices suggests efforts to build professional validation [Maypall.com].
No public information covers manufacturing scale, supply chain, or regulatory certifications like FDA approval for safety claims.
Data Accuracy: ORANGE -- Product details and claims are sourced solely from the company's website and have not been independently verified through third-party testing, customer reviews, or regulatory filings.
Market Research and Opportunity
PUBLIC
Consumer shift toward natural, ingestible wellness products creates a niche in oral care. Safety and ingredient transparency drive purchases.
For MayPall, the opportunity targets parents and health-conscious adults dissatisfied with alcohol, fluoride, or artificial ingredients. They seek child-safe products.
Public market sizing for "safe-to-swallow, natural mouthwash" lacks third-party reports. Broader oral care provides context. Grand View Research valued the global market at $45 billion in 2023, with mouthwash significant [Grand View Research, 2023].
Natural and organic personal care grows steadily. Tailwinds include parental fluoride concerns, clean-label preference, and oral microbiome awareness. These suggest expanding SAM in natural oral care, though unquantified publicly.
Adjacent markets: pediatric dental products, functional beverages, supplements. Regulatory forces cut both ways. FDA regulates mouthwash as cosmetic or OTC drug for therapeutic claims. MayPall's safety and cavity prevention marketing could draw scrutiny. Cosmetic claims allow faster entry.
Macro forces like natural ingredient supply chains pose operational risk.
Given absent category sizing, analogous figures frame the opportunity.
| Market Segment | Size (Estimated) | Source | Year |
|---|---|---|---|
| Global Oral Care Market | $45 billion | Grand View Research | 2023 |
| U.S. Mouthwash & Dental Rinse Market | $6.4 billion | Statista | 2023 |
| Global Natural & Organic Personal Care Market | $13.3 billion | Grand View Research | 2023 |
MayPall operates in a large, mature market but targets high-growth premium niche. Success depends on defining "safe-to-swallow" category, converting from substitutes like fluoride-free toothpaste.
Data Accuracy: YELLOW -- Market sizing is based on analogous, broad industry reports; specific TAM for the target niche is not publicly confirmed.
Competitive Landscape
MIXED MayPall enters a fragmented oral care market. Large incumbents, natural challengers, and substitutes define it. Positioning rests on a single product claim.
Direct competitors: natural, xylitol-based DTC mouthwashes. MayPall's scientific origin differentiates, but commercial maturity lags.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| MayPall Inc | Natural, safe-to-swallow mouthwash for all ages, based on university research into maple/green tea compounds. | Pre-Seed; gBETA accelerator participant. | Academic spinout with a formulation specifically researched for bacterial adhesion prevention; emphasizes safety for children. | [Maypall.com]; [wyomingnews.com, July 2024] |
| RiseWell | Mineral-based oral care (toothpaste, mouthwash) focused on hydroxyapatite and xylitol for enamel remineralization. | Venture-backed (Seed $2.1M in 2021). | Uses hydroxyapatite as a fluoride alternative; strong branding around 'dentist-formulated' and clean ingredients. | [risewell.com]; [Crunchbase] |
| ORL | Organic, non-GMO oral care with xylitol mouthwash, positioned as a 'clean' alternative to mainstream brands. | Private company; funding not disclosed. | Focus on certified organic ingredients and transparent sourcing; product line includes toothpaste, floss, and brushes. | [orlcares.com] |
| Spry | Xylitol-focused oral care products (toothpaste, gum, mouthwash) marketed for cavity prevention and fresh breath. | Brand owned by Xlear Inc. | Long-established brand (since 1999) in the xylitol space; wide retail distribution in stores like Whole Foods and on Amazon. | [Amazon] |
Segment map. Competition splits into tiers. Mass-market incumbents like Listerine (Johnson & Johnson) and Crest (Procter & Gamble) dominate with fluoride formulas.
Natural challengers form the middle tier: MayPall, RiseWell, ORL, Spry. They avoid alcohol, fluoride, artificials, competing on purity and DTC. Adjacent substitutes: Boka (nano-hydroxyapatite), Bite toothpaste tablets.
Defensible edge. MayPall's edge is proprietary scientific narrative from Professor Mark Gomelsky's research [Cowboy State Daily, Oct 2025]. Maple and green tea compounds prevent bacterial sticking. This is unique but perishable: no visible patents, reverse-engineerable, product-narrow without distribution or clinical moats.
Exposure points. DTC subscription faces RiseWell, ORL competition. Spry's retail is hard to match. Largest exposure: unvalidated 'safe to swallow' claim, regulatory hurdle. RiseWell focuses on enamel, less risky.
18-month scenario. Fragmentation likely determines winners by capital, channels. Winner: RiseWell with backing, range. Loser: MayPall as niche if no seed, team, metrics; single SKU vulnerable.
Data Accuracy: YELLOW -- Competitor profiles drawn from company websites and Crunchbase; MayPall's positioning is from its own site and local press. Funding for RiseWell is from a single source; other competitor stages are inferred from commercial activity.
Opportunity
PUBLIC The prize for MayPall is high-margin, high-growth natural oral care. A validated, science-backed child-safe product could command share, loyalty.
Headline opportunity. Dominate natural children's oral care. Mass brands not swallowable. 'Safe to swallow' addresses parental concern, defensible wedge. Product built, DTC subscription live, accelerator nod [wyomingnews.com, July 2024]. Science story credible [Maypall.com].
Growth scenarios. Plausible paths beyond DTC.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Professional Endorsement | Pediatric dentists and hygienists recommend MayPall as a safe, daily-use rinse, driving consumer adoption through trusted authority. | A formal partnership or distribution deal with a major dental supply company or professional association. | The company is already soliciting samples from dental offices, indicating a clear channel strategy [Maypall.com]. The product's academic backing is a natural fit for professional credibility. |
| Category Expansion | MayPall leverages its core "safe-to-swallow" technology and brand trust to launch a full suite of pediatric oral care products (toothpaste, floss, chewables). | Successful proof of concept and brand recognition from the initial mouthwash line, followed by a new product launch. | The DTC model and subscription service create a direct relationship with customers, making cross-selling new SKUs a logical next step to increase customer lifetime value. |
Compounding. Brand, data flywheel. Subscriptions yield revenue, data. Positive experiences fuel WOM, reviews, lower CAC. Professional endorsement creates B2B2C loop.
Subscription provides cash flow, loyalty barrier.
Win size. Hello Products acquired by Colgate 2020. RiseWell comparable. DTC wellness 3x-5x multiples. Professional endorsement in pediatric practices: tens of millions brand value.
Data Accuracy: YELLOW -- Growth scenarios are extrapolated from stated company activities; the core product claims and accelerator participation are confirmed.
Sources
PUBLIC
[Cowboy State Daily, Oct 2025] The Laramie Lab Geniuses Leading Wyoming's Biotech Boom | https://cowboystatedaily.com/2025/10/24/biotech-boom-laramies-lab-geniuses-transform-maple-and-bacteria-into-big-breaks/
[Maypall.com] Home | Maypall: Natural, Effective, and Safe to Swallow Mouthwash | https://www.maypall.com/
[wyomingnews.com, July 2024] Laramie-based MayPall among state startups selected for accelerator | https://www.wyomingnews.com/laramieboomerang/news/laramie-based-maypall-among-state-startups-selected-for-accelerator/article_0319c87a-3002-11ef-87c2-2f1539642fb9.html
[Grand View Research, 2023] Global Oral Care Market Size Report, 2023-2030 | https://www.grandviewresearch.com/industry-analysis/oral-care-market
[Statista, 2023] Mouthwash & Dental Rinse Market in the U.S. | https://www.statista.com/outlook/cmo/oral-care/mouthwash-dental-rinse/united-states
[risewell.com] RiseWell Balancing Mouthwash with Xylitol | https://risewell.com/products/balancing-mouthwash
[Crunchbase] RiseWell Company Profile & Funding | https://www.crunchbase.com/organization/risewell
[orlcares.com] Compare ORL's Natural, Organic Xylitol Mouthwash with Your Brand | https://orlcares.com/pages/mouthwash-brand-page-2020-copy
[Amazon] Spry Natural Xylitol Mouthwash | https://www.amazon.com/Spry-Mouthwash-Xylitol-Alcohol-Support/dp/B01N1RPCS4
Articles about MayPall Inc
- MayPall Is Selling a Swallowable Mouthwash to Kids and Their Dentists — The Wyoming spinout, backed by university research, aims to replace fluoride rinses with a natural formula safe enough to ingest.